AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Chemical Market Reporter)
Mylan Laboratories has obtained FDA approval to market the Parkinson's disease treatment Apokyn (injection apomorphine HCl). This will be launched in the US in Jul 2004. The registration was made through subsidiary Bertek Pharmaceuticals. It is produced by the …